Effect of Number of Previous Antiseizure Medications on Efficacy and Tolerability of Adjunctive Brivaracetam for Uncontrolled Focal Seizures: Post Hoc Analysis

被引：0
|
作者：
Sang-Kun Lee
Kyoung Heo
Sung-Eun Kim
Sang-Ahm Lee
Sami Elmoufti
Cédric Laloyaux
Boeun Hur
机构：
[1] Seoul National University Hospital,Department of Neurology, Seoul National University College of Medicine
[2] Severance Hospital,Department of Neurology, Yonsei University College of Medicine
[3] Inje University College of Medicine,Department of Neurology, Haeundae Paik Hospital
[4] University of Ulsan College of Medicine,Department of Neurology, Asan Medical Center
[5] UCB Pharma,undefined
[6] UCB Pharma,undefined
[7] UCB Pharma,undefined
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Anti-epileptic drugs; Antiseizure medications; Brivaracetam; Drug-resistant epilepsy; Drug-resistant focal seizures; Efficacy; Focal epilepsy; Tolerability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4082 / 4099
页数：17
相关论文
共 50 条
  • [31] Efficacy, safety, and tolerability of adjunctive brivaracetam in adult Asian patients with uncontrolled focal-onset seizures: A phase III randomized, double-blind, placebo-controlled trial
    Inoue, Yushi
    Tiamkao, Somsak
    Zhou, Dong
    Cabral-Lim, Leonor
    Lim, Kheng Seang
    Lim, Shih-Hui
    Tsai, Jing-Jane
    Moseley, Brian
    Wang, Lin
    Sun, Weiwei
    Hayakawa, Yoshinobu
    Sasamoto, Hiroshi
    Sano, Tomonobu
    Mcclung, Carrie
    Bass, Almasa
    EPILEPSIA OPEN, 2024, 9 (03) : 1007 - 1020
  • [32] EFFECT OF ADJUNCTIVE PERAMPANEL ON MYOCLONIC AND ABSENCE SEIZURES: A POST HOC ANALYSIS
    Brandt, C.
    Wechsler, R. T.
    O'Brien, T. J.
    Laurenza, A.
    Patten, A.
    Bibbiani, F.
    Williams, B.
    EPILEPSIA, 2017, 58 : S109 - S109
  • [33] Efficacy of cenobamate for uncontrolled focal seizures in patients with previous epilepsy-related surgery: Post hoc analysis of a phase 3, multicenter, open-label study
    Abou-Khalil, Bassel
    Aboumatar, Sami
    Klein, Pavel
    Krauss, Gregory L.
    Sperling, Michael R.
    Rosenfeld, William E.
    EPILEPSY RESEARCH, 2022, 184
  • [34] Efficacy and Tolerability of Adjunctive Lacosamide in Children and Adolescents with Uncontrolled Focal Seizures: A Randomized, Double-blind, Placebo-controlled
    Farkas, V
    Steinborn, B.
    Flamini, J.
    Dilley, D.
    Bozorg, A.
    Daniels, T.
    Scheffer, I
    ANNALS OF NEUROLOGY, 2017, 82 : S287 - S290
  • [35] Post hoc analysis of a phase 3 study for treatment of uncontrolled focal seizures: Adjunctive cenobamate dose and seizure reduction by baseline seizure frequency
    Aboumatar, Sami
    Biton, Victor
    Wechsler, Robert
    Ferrari, Louis
    Rosenfeld, William E.
    EPILEPSY RESEARCH, 2022, 186
  • [36] Efficacy of Cenobamate for Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study
    Sperling, Michael R.
    Abou-Khalil, Bassel
    Aboumatar, Sami
    Bhatia, Perminder
    Biton, Victor
    Klein, Pavel
    Krauss, Gregory L.
    Vossler, David G.
    Wechsler, Robert
    Ferrari, Louis
    Kamin, Marc
    Grall, Mindy
    Rosenfeld, William E.
    NEUROLOGY, 2021, 96 (15)
  • [37] Efficacy and safety of adjunctive cenobamate: Post-hoc analysis of study C017 in patients grouped by mechanism of action of concomitant antiseizure medications
    Brandt, Christian
    Carlos Sanchez-Alvarez, Juan
    Steinhoff, Bernhard J.
    Milanov, Ivan
    Serratosa, Jose M.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2022, 96 : 86 - 93
  • [38] Safety and tolerability of adjunctive brivaracetam in children with focal seizures: Interim analysis of pooled data from two open-label trials
    Patel, Anup D.
    Badalamenti, Vincent
    Gasalla, Teresa
    Elmoufti, Sami
    Elshoff, Jan-Peer
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2020, 25 : 68 - 76
  • [39] Sensitivity and responsiveness of the EQ-5D-3L in patients with uncontrolled focal seizures: an analysis of Phase III trials of adjunctive brivaracetam
    Clara Mukuria
    Tracey Young
    Anju Keetharuth
    Simon Borghs
    John Brazier
    Quality of Life Research, 2017, 26 : 749 - 759
  • [40] Health-related quality of life in double-blind Phase III studies of brivaracetam as adjunctive therapy of focal seizures: A pooled, post-hoc analysis
    Brandt, Christian
    Borghs, Simon
    Elmoufti, Sami
    Mueller, Knut
    Townsend, Rebecca
    de la Loge, Christine
    EPILEPSY & BEHAVIOR, 2017, 69 : 80 - 85
12345